Boston Scientific Corporation has welcomed the results of a new study, led by Dr Marc Bosiers of Belgium, demonstrating that the closed cell design of Boston Scientific’s Carotid WALLSTENT Monorail provides superior clinical outcomes compared to open cell carotid stents.
The study compares the clinical results of open versus closed cell carotid stents in 709 patients. At 30 days post procedure, symptomatic patients that received the closed cell stent showed a 4.1 times reduction of stroke, transient ischemic attacks (TIA, a major predictor of stroke) or death – compared to the open cell stent group. The Carotid WALLSTENT Monorail represented more than 70% of the closed cell stents used in this study. Closed cell stents, such as Boston Scientific’s Carotid WALLSTENT Monorail, have overlapping or fully connecting struts and cover 5 to 10 times more of the vascular wall as compared to open cell stents that have both connecting and non-connecting struts.